---
title: Quant by SwitzerlandOmics
layout: page
description: Pitch
permalink: "/pitch/"
intro_image_absolute: true
intro_image_hide_on_mobile: false
---

**Quant is the critical layer that makes genomics work: interpretable, actionable, and accountable.**  

*Technically sound. Incredibly simple.*

---

**Company name:**
*SwitzerlandOmics GmbH* (in formation)

**Website:**
[SwitzerlandOmics.ch](https://switzerlandomics.ch)

**Founders:**
12 years of PhD-level experience in applied genomics and statistical modelling.
Backed by federal funding, national-scale clinical studies, and a proven track record of delivering complex projects on time and on budget-including six years of development across UZH, EPFL, and ETH Zurich.

**Stage:** Pre-incorporation

**Grant requested:** CHF 10,000 for company registration and secure data hosting.

---

## ðŸ§­ The gap

**Genomics has extraordinary promiseâ€”but it remains underused.**
From patient diagnosis to drug development, medical decisions depend on understanding how genetic variants cause disease. Sequencing is fast and affordable. But one thing is still missing:

> A systematic, probability-based framework to interpret genetic variantsâ€”across all genes, inheritance modes, and evidence types.

Despite over a century of theoretical groundwork, this problem has never been solved. Until now.

---

## ðŸ§¬ Our Solution: Quant

**Quant is a statistical engine and product suite that delivers calibrated, genome-wide probabilities of disease causality.**
It includes three interoperable components:

* **Quant database** - pre-computed, licensable genome-wide priors.
* **Quant scan** - applies priors to real-world variant data for case interpretation.
* **Quant calc** - licensable algorithms to perform full probabilistic inference on new datasets.

Key capabilities:

* Priors tailored for autosomal dominant, recessive, and X-linked models.
* Integration of allele frequencies, Hardy-Weinberg equilibrium, ClinVar classifications, and uncertainty.
* Outputs **credible intervals** and variant-/gene-level disease probabilities.
* Validated on national-level cohorts across immune and rare disease genetics.

---

## ðŸ§± Product maturity

* **6 years of development** at UZH, EPFL, ETH Zurich
* **Peer-reviewed publications** and real-world validation
* Tools ready for use: **Quant database**  **Quant scan**, **Quant calc**, **PanelAppRex AI**, **QV database**

---

## ðŸ’° Use of funds (CHF 10,000)

| Purpose                        | Estimate  |
| ------------------------------ | --------- |
| Legal & incorporation (GmbH)   | CHF 3,000 |
| Legal setup & banking          | CHF 2,000 |
| Secure Swiss-based hosting     | CHF 3,500 |
| Launch of public Quant dataset | CHF 1,500 |

*Enables legal formation, privacy-compliant infrastructure, and first release of our public-calibrated dataset.*

---

## ðŸŒ Impact

Quant makes variant interpretation **transparent, scalable, and reproducible**. It enables:

* **Clinical diagnostics** with confidence
* **AI genomics models** trained on real probability
* **Pharma & research** to quantify risk across genes and inheritance modes

We provide the statistical foundation modern genomics has been missing.

> *SwitzerlandOmics is building the missing layer between raw DNA and confident interpretation.*

---

## âœ… Request

* CHF 10,000 seed grant for incorporation and infrastructure
* Additional materials available: pitch deck, data preview, letters of support

---


<!-- ## A century-old challenge, a modern solution -->

<!-- **Analogy:** -->
<!-- In the early 1900s, Sam Zemurray revolutionized the banana industry by seeing value where others saw wasteâ€”selling ripe bananas locally when everyone else focused on unripe fruit for long distances. He solved a logistics problem and changed an industry. -->

<!-- **The Problem (in simple terms):** -->
<!-- Today, genomics faces its own century-old challenge: despite incredible advances in DNA sequencing, we still struggle to reliably interpret what genetic variations mean for health, drug discovery, and personalized medicine. -->

<!-- **The Solution (in simple terms):** -->
<!-- Quant is our answer. It transforms complex genetic data into clear, probabilistic insights. Just as Zemurray turned overlooked bananas into a market advantage, Quant turns genetic uncertainty into actionable knowledge. -->

<!-- **The Scientific Side:** -->
<!-- Built on rigorous Bayesian statistics, population genetics, and years of real-world testing, Quant provides a systematic, probability-based framework for interpreting genetic variants. -->

---
